Is Deciem (The Ordinary) profitable?

No standalone financials are published since Deciem is fully consolidated into Estee Lauder's Skin Care segment. That segment grew organic sales 3% in fiscal Q1 2026 (quarter ended Sept 30, 2025), with The Ordinary leading growth and gaining US market share for a third straight quarter, per ELC's Oct 30, 2025 report.

Who owns The Ordinary and Deciem?

The Estee Lauder Companies (NYSE: EL) completed a full acquisition of Deciem on May 31, 2024, paying an estimated $860 million for the final tranche, bringing cumulative investment across three tranches since 2017 to roughly $1.7 billion. Deciem is now a wholly owned ELC subsidiary.

Could AI replace The Ordinary or Deciem?

No, its value is a physical, manufactured product line AI cannot make or ship. Instead, a July 2, 2026 Beauty AI Visibility Index found The Ordinary leads all beauty brands in AI Citation Share at 7.0% across ChatGPT, Claude, Perplexity, Gemini and Google AI Overviews, ahead of CeraVe at 6.0%.

Is The Ordinary losing to CeraVe?

Not currently. The Ordinary ranks first in AI Citation Share at 7.0% versus CeraVe's 6.0% as of July 2, 2026, and gained US market share for three consecutive quarters through ELC's fiscal Q1 2026 (Oct 30, 2025). L'Oreal's CeraVe remains the closest scaled rival in derm-positioned skincare.

What is The Ordinary's biggest competitor?

The Inkey List is most frequently cited as The Ordinary's closest direct rival in ingredient-forward, budget skincare across independent buying guides as of December 5, 2025, with Good Molecules, Naturium and e.l.f. Skin also named as cloned-positioning competitors.

Are Deciem's direct online sales growing?

No. Deciem's own web store (deciem.com) generated $6.5 million in 2025, down 20 to 50% year over year, per Grips Intelligence data published May 25, 2026, which forecasts a 10 to 20% rebound in 2026. This tracks only the DTC channel, not total retail and wholesale revenue.

Consumer brands · subsidiary of The Estée Lauder Companies Inc. (NYSE: EL) · Canada

Deciem (The Ordinary)

theordinary.com ↗

Canadian skincare brand behind The Ordinary, majority owned by Estée Lauder.

Defensible for now

Assessed 23 July 2026 · Evidence as of 23 July 2026

Real protection, with named pressure against it.

On the recordSince 23 July 2026 · Checkable from ~August 2026 · Every call on the record Checkpoint: ELC fiscal Q2 2026 earnings report on skin care segment and The Ordinary's share trend

The call

The Ordinary currently wins the AI recommendation game and the sales numbers, inside a parent company that is cutting costs across its skincare portfolio.

The Ordinary sells cheap, simple skincare products online and in stores, built by a company that L'Oréal bought and still owns completely. It is hard to copy because it has loyal customers, sells through many stores, and makes its own products, but L'Oréal's other brands like CeraVe do similar things and AI search engines can shift which brand people find and buy first. The biggest question is whether L'Oréal will keep investing in The Ordinary or sell it off as the parent company cuts costs and focuses on other beauty lines.

Why

AI pressure: AI chatbots and search overviews (ChatGPT, Perplexity, Google AI Overviews). The Ordinary tops AI skincare recommendations at 7.0% citation share, but that ranking resets monthly and CeraVe sits close behind at 6.0%. Could AI do the core job? Unlikely.

Bigger players: L'Oréal (CeraVe, La Roche-Posay). L'Oréal's CeraVe already rivals The Ordinary in AI recommendation share and has far deeper mass retail shelf space. Could a giant copy it? Probably.

What protects it. Estée Lauder's distribution, marketing budget, and manufacturing now sit behind a brand built on cheap, ingredient-led formulas.

What would change this call

ELC reports a quarter where The Ordinary's US market share declines instead of gains. Would show CeraVe or other rivals are finally converting buzz into taken share.
ELC names Deciem in any 'Beauty Reimagined' divestiture or shared-services folding announcement. Would show parent deprioritizing Deciem versus other brands in the portfolio.
Deciem's direct web store revenue fails to rebound in 2026 after 2025's 20-50% YoY drop. Would show demand softness extending beyond one-off factors into sustained decline.

Key numbers

7.0% AI citation share, ranked #1 in beauty (2026-07-02)
3 straight quarters of US share gains (2025-10-30)
ELC skin care sales fell 12% to $6.96B (2025-08-20)

Named risks

ELC's multi-year cost restructuring could deprioritize Deciem investment or Toronto operating independence. Severity: medium
Direct-to-consumer web sales fell 20-50% year over year in 2025 per Grips Intelligence. Severity: medium
Single-active-ingredient formula positioning is easily replicated by Inkey List, Naturium, Good Molecules. Severity: medium
AI citation share leadership is platform-determined and re-rollable monthly, not company-controlled. Severity: low
As a wholly owned subsidiary, Deciem has no independent equity and is exposed to ELC portfolio pruning decisions. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
CeraVe (L'Oreal)	contesting	CeraVe ranks 2nd in AI citation share at 6.0% vs The Ordinary's 7.0%, July 2, 2026
The Inkey List	contesting	Named closest direct rival in budget ingredient-transparent skincare, Dec 5, 2025
La Roche-Posay (L'Oreal)	contesting	Ranks 5.0% AI citation share vs The Ordinary's 7.0%, July 2, 2026
Naturium, Good Molecules, e.l.f. Skin	gaining on	Cloned low-cost, transparent-ingredient positioning cited across 2025-2026 buying guides
Charlotte Tilbury	contesting	Ranks 4.5% AI citation share, below The Ordinary's 7.0%, July 2, 2026

Questions people ask

Is Deciem (The Ordinary) profitable?: No standalone financials are published since Deciem is fully consolidated into Estee Lauder's Skin Care segment. That segment grew organic sales 3% in fiscal Q1 2026 (quarter ended Sept 30, 2025), with The Ordinary leading growth and gaining US market share for a third straight quarter, per ELC's Oct 30, 2025 report.
Who owns The Ordinary and Deciem?: The Estee Lauder Companies (NYSE: EL) completed a full acquisition of Deciem on May 31, 2024, paying an estimated $860 million for the final tranche, bringing cumulative investment across three tranches since 2017 to roughly $1.7 billion. Deciem is now a wholly owned ELC subsidiary.
Could AI replace The Ordinary or Deciem?: No, its value is a physical, manufactured product line AI cannot make or ship. Instead, a July 2, 2026 Beauty AI Visibility Index found The Ordinary leads all beauty brands in AI Citation Share at 7.0% across ChatGPT, Claude, Perplexity, Gemini and Google AI Overviews, ahead of CeraVe at 6.0%.
Is The Ordinary losing to CeraVe?: Not currently. The Ordinary ranks first in AI Citation Share at 7.0% versus CeraVe's 6.0% as of July 2, 2026, and gained US market share for three consecutive quarters through ELC's fiscal Q1 2026 (Oct 30, 2025). L'Oreal's CeraVe remains the closest scaled rival in derm-positioned skincare.
What is The Ordinary's biggest competitor?: The Inkey List is most frequently cited as The Ordinary's closest direct rival in ingredient-forward, budget skincare across independent buying guides as of December 5, 2025, with Good Molecules, Naturium and e.l.f. Skin also named as cloned-positioning competitors.
Are Deciem's direct online sales growing?: No. Deciem's own web store (deciem.com) generated $6.5 million in 2025, down 20 to 50% year over year, per Grips Intelligence data published May 25, 2026, which forecasts a 10 to 20% rebound in 2026. This tracks only the DTC channel, not total retail and wholesale revenue.

Timeline

2026-07-02AI Citation Share report ranks The Ordinary #1 among beauty brands at 7.0%, ahead of CeraVe 6.0%
2026-05-01ELC makes minority investment in luxury skin brand 111Skin
2025-10-30ELC reports fiscal Q1 2026 results, The Ordinary gains US share for 3rd straight quarter
2025-10-16The Ordinary launches 'Periodic Fable' anti-jargon marketing campaign
2025-09-10Lattice case study details Deciem HR team growth to about 43 people
2025-08-20ELC reports fiscal 2025 skin care net sales fell 12% to $6.96B
2025-05-01The Ordinary expands to Amazon Premium Beauty US and TikTok Shop Thailand
2024-06-03Estee Lauder completes full acquisition of Deciem, cumulative investment ~$1.7B

Revision history

23 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

Estée Lauder LVMH Moet Hennessy Louis Vuitton Chow Sang Sang Holdings International Limited